Algernon Pharmaceuticals Inc.
AGN
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 367.95% | 378.14% | 39.80% | -65.33% | -89.28% |
| Total Receivables | -9.43% | -83.66% | -87.24% | -66.32% | -93.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.78% | 7.18% | -16.53% | -90.29% | -92.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 238.80% | 118.13% | 16.55% | -74.11% | -90.82% |
|
|
|||||
| Total Current Assets | 238.80% | 118.13% | 16.55% | -74.11% | -90.82% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -18.44% | -16.06% | -40.23% | -28.12% | -28.39% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.30% | -49.88% | -88.73% | -88.70% | -50.12% |
| Total Assets | -10.40% | -5.66% | -36.81% | -34.32% | -40.95% |
|
|
|||||
| Total Accounts Payable | -37.85% | -34.97% | -27.29% | 32.23% | 34.12% |
| Total Accrued Expenses | -62.59% | 40.50% | 3,060.00% | 761.17% | -31.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -38.46% | -34.51% | -20.34% | 44.02% | 30.99% |
|
|
|||||
| Total Current Liabilities | -38.46% | -34.51% | -20.34% | 44.02% | 30.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -38.46% | -34.51% | -20.34% | 44.02% | 30.99% |
|
|
|||||
| Common Stock & APIC | 1.71% | 5.32% | 3.59% | 6.58% | 3.06% |
| Retained Earnings | 3.79% | -0.20% | -7.57% | -12.87% | -15.38% |
| Treasury Stock & Other | -22.72% | -17.89% | -16.45% | -28.90% | -2.27% |
| Total Common Equity | 71.02% | 47.59% | -47.49% | -87.78% | -77.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 71.02% | 47.59% | -47.49% | -87.78% | -77.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 71.02% | 47.59% | -47.49% | -87.78% | -77.23% |
|
|
|||||